Phyllis Gotlib, serving as President of International at American Well Corp (NASDAQ: AMWL), completed a mandatory share transaction on July 1, 2026. The action involved the disposition of 6,677 shares of the company's Class A Common Stock. Executed at a price of $9.33 per share, the total value of the transaction reached approximately $62,296.
Crucially, this disposition was not a discretionary trade initiated by Ms. Gotlib. Instead, it functions as an automatic sell-to-cover mechanism designed to satisfy tax liabilities generated by the vesting and settlement of restricted stock units on the identical date. This type of transaction is routine for fulfilling tax obligations associated with equity compensation.
Following the execution of these transactions, Ms. Gotlib's direct holdings in American Well Corp Class A Common Stock stand at 152,754 shares. Furthermore, her husband maintains indirect ownership of 114,920 shares. According to InvestingPro analysis, AMWL appears undervalued at current levels, with 10 additional ProTips available to subscribers seeking deeper insights into the company's prospects.
Amwell reported its first-quarter 2026 financial results, revealing a total revenue of $54.9 million. This figure represents an 18% year-over-year decline. The decrease was attributed mainly to customer churn. Despite the revenue drop, Amwell made progress toward profitability, achieving a 43% improvement in its operating loss. Meanwhile, Truist Securities reiterated its Hold rating on Amwell shares, setting a price target of $7.50.
In leadership developments, Dr. Roy Schoenberg, co-founder of Amwell, has resigned from the company's board of directors to pursue a new employment opportunity. This change follows Amazon's announcement that Dr. Schoenberg will lead its healthcare business starting July 1. Additionally, Amwell's digital mental health platform, SilverCloud, showed positive results in a study involving over 6,000 students at high risk for anxiety, depression, or eating disorders. The study, funded by the National Institute of Mental Health, was conducted across 26 U.S. colleges and universities.
Market data indicates AMWL closed at $9.39, reflecting a gain of $0.27 or 2.96%. After-hours trading showed the stock at $9.57, up $0.20 or 2.13%. The article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Is AMWL a bargain right now? The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for AMWL plus thousands of other stocks and find your next hidden gem with massive upside. See Undervalued Stocks.